ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2020

Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score-Matched Analysis from the Korean College of Rheumatology Biologics Registry.

Hyoun-Ah Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.